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Abstract
Background: Kinetics of inhaled agents are often described by physiological models. However,
many pharmacokinetic concepts, such as context-sensitive half-times, have been developed for
drugs described by classical compartmental models. We derived classical compartmental models
that describe the course of the alveolar concentrations (FA) generated by the physiological uptake
and distribution models used by the Gas Man® program, and describe how distribution volumes
and clearances relate to tissue volumes and blood flows.
Methods: Gas Man® was used to generate FA vs. time curves during the wash-in and wash-out
period of 115 min each with a high fresh gas flow (8 L.min-1), a constant alveolar minute ventilation
(4 L.min-1), and a constant inspired concentration (FI) of halothane (0.75%), isoflurane (1.15%),
sevoflurane (2%), or desflurane (6%). With each of these FI, simulations were ran for a 70 kg patient
with 5 different cardiac outputs (CO) (2, 3, 5, 8 and 10 L.min-1) and for 5 patients with different
weights (40, 55, 70, 85, and 100 kg) but the same CO (5 L.min-1). Two and three compartmental
models were fitted to FA of the individual 9 runs using NONMEM. After testing for parsimony,
goodness of fit was evaluated using median prediction error (MDPE) and median absolute
prediction error (MDAPE). The model was tested prospectively for a virtual 62 kg patient with a
cardiac output of 4.5 L.min-1 for three different durations (wash-in and wash-out period of 10, 60,
and 180 min each) with an FI of 1.5% halothane, 1.5% isoflurane, sevoflurane 4%, or desflurane 12%.
Results: A three-compartment model fitted the data best (MDPE = 0% and MDAPE ≤ 0.074%) and
performed equally well when tested prospectively (MDPE ≤ 0.51% and MDAPE ≤ 1.51%). The
relationship between CO and body weight and the distribution volumes and clearances is complex.
Conclusion: The kinetics of anesthetic gases can be adequately described e by a mammilary
compartmental model. Therefore, concepts that are traditionally thought of as being applicable to
the kinetics of intravenous agents can be equally well applied to anesthetic gases. Distribution
volumes and clearances cannot be equated to tissue volumes and blood flows respectively.
Background
Like intravenous anesthetics, inhaled anesthetic agents
can and are being safely administered without the knowl-
edge of any pharmacokinetic model. In addition, the
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MAC and MAC awake concept link the end-expired con-
centrations (FA) with the clinically two most relevant end-
points, immobility and unconsciousness. Kinetic models
can nevertheless be useful. Models are used to explain dif-
ferences in wash-in and wash-out characteristics of differ-
ent agents that may be relevant to clinical practice. Uptake
models have also been used to try to predict the relation-
ship between fresh gas flow, and delivered, inspired (FI),
and end-expired concentrations of anesthetic agents in the
commonly used circle breathing system [1]. Once a
kinetic model has been developed, it can be linked to clin-
ically relevant endpoints (immobility and unconscious-
ness) by incorporating an effect site compartment.
Physiological models are appealing because they can be
understood in terms of anatomy, physiology, and physics.
The kinetics of inhaled agents are commonly described
using physiological modeling because of the availability
of values for tissue partition coefficients, tissue volumes
and organ blood flows. Yet many assumptions underlie
these models, such as the absence of an arterial-end-
expired gradient or the assumption that uptake and distri-
bution in an organ is uniform and instantaneous as
implicitly assumed by flow limited uptake and the use of
a single value for tissue partition coefficients [2]. In addi-
tion, it is mathematically impossible to accurately fit all
these parameters to "uptake" as it is clinically available in
the operating room: the product of inspired concentration
(FI) and ventilation minus the product of the end-expired
concentration (FA) and ventilation. A parsimonious
empirical polyexponential model ("classical compart-
mental modeling") similar to that used to describe the
course of the concentration over time of intravenous
agents may be better suited to analyze the partial pressure
(or infusion rate) of potent inhaled anesthetics over time
[3-5]. The first goal of this manuscript is to examine
whether the kinetics of four different anesthetic agents
generated by a physiological uptake model (used by the
Gas Man® program, Med Man Simulations, Inc., Chestnut
Hill, MA) can be equally well described by a mammilary
compartmental model (derived using non-linear mixed
effect modeling or NONMEM) [6]. If so, concepts applied
to intravenous agents, like the context-sensitive half time,
would also be applicable to inhaled agents. The derived
compartmental model will be prospectively tested against
the physiological model used by the Gas Man® program.
More detail about both models is provided in the Appen-
dix. The second goal of this manuscript is to address the
controversial issue whether or to what an extent distribu-
tion volumes and clearances relate to tissue volumes and
blood flows. We therefore examined whether distribution
volumes and clearances match the tissue volumes and
blood flows from the physiological model used to gener-
ate the data from which the parameters of the compart-
mental model were derived.
Methods
Part I: Deriving the kinetic parameters of the 
compartmental model
Gas Man® was used to generate FA for 4 different agents
(halothane, isoflurane, sevoflurane, and desflurane) dur-
ing a wash-in and washout period of 115 min each with a
high fresh gas flow (8 L.min-1) and a constant alveolar
minute ventilation (4 L.min-1, regardless of patient
weight). The default settings were used for the circuit and
tissue composition. The inspired concentrations of
halothane, isoflurane, sevoflurane, and desflurane were
maintained constant during the wash-in period at 0.75;
1.15; 2; and 6% respectively. With each of these inspired
concentrations, simulations were run for a 70 kg patient
with 5 different cardiac outputs (2, 3, 5, 8 and 10 L.min-1)
and for 5 patients with different weights (40, 55, 70, 85,
and 100 kg) but the same cardiac output (5 L.min-1). This
yielded 9 unique simulations for each agent (note that
each group includes a 70 kg patient with a cardiac output
of 5 L.min-1, which is why there were not 10 unique sim-
ulations). Two and three compartmental models were fit-
ted to FA of the individual 9 simulations using NONMEM
(the original data and the NONMEM control code are
available in the Web supplement). The total administered
dose was entered in the NONMEM data file as the product
of the inspired concentration and duration. A naïve
pooled data fit was done to obtain starting values for the
structural parameters (distribution volumes and clear-
ances) for each of the four agents. The effect of weight and
cardiac output on each of the structural parameters (cov-
ariate analysis) was assessed using the minimum objective
function of NONMEM, -2 × Log Likelihood (-2LL), to
decide whether to accept or omit a covariate. The results
were then tested for parsimony by sequentially deleting
each of the covariate parameters using the NONMEM
objective function as the criteria to accept or delete any
covariate parameter. Goodness of fit was evaluated using
median prediction error (MDPE) and median absolute
prediction error (MDAPE) as a measure for bias and accu-
racy respectively [7]. MDPE and MDAPE were calculated
as (FAGas Man - FA3compartmental model)/
FA3compartmental model) and |(FAGas Man -
FA3compartmental model)/FA3compartmental model|
respectively, and are expressed in %.
Part II: Prospective testing of the compartmental model
Using the previously derived parameters with their covari-
ates, the compartmental model was tested prospectively
by having it generate FA for a patient with parameters dif-
ferent from those from which the model was derived. The
FA output for a 62 kg patient with a cardiac output of 4.5
L.min-1 for three different durations (wash-in and wash-
out period of 10, 60, and 180 min each) with an FI of
1.5% halothane, 1.5% isoflurane, sevoflurane 4%, or des-
flurane 12% was calculated by converting the volume andBMC Anesthesiology 2006, 6:7 http://www.biomedcentral.com/1471-2253/6/7
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clearance parameters, including any covariate effects, into
the coefficients and exponents defining the three expo-
nential functions that together describe the FA course.
Conversions were done with the Excel spreadsheet CON-
VERT.XLS [8]. The same patient parameter set was entered
into Gas Man® and the respective end-expired concentra-
tions were obtained. The predictive performance of the
compartmental model was tested using MDPE and
MDAPE as described above. MDPE and MDAPE less than
20% have been considered acceptable. All data and con-




A three compartment model best described the FA course.
The distribution volumes and clearances for each of the
initial 9 simulation runs are presented in figure 1 and 2.
The pharmacokinetic parameters for the three compart-
mental model with cardiac output and weight as covari-
ates (tested for parsimony) are presented in (Table 1 and
2). As shown in table 2, the models described the data
almost perfectly (MDPE = 0% and MDAPE ≤ 0.074%),
indicating that a 3 compartment mammilary model is suf-
ficient to capture the pharmacokinetic behavior of the
anesthetic gases in a high flow open circuit.
Part II
FA of each of the four agents generated by the compart-
mental model and the corresponding values from Gas
Man® are illustrated in figure 3. Goodness of fit was excel-
lent (MDPE ≤ 0.51% and MDAPE ≤ 1.51%) (Table 2).
Discussion
The time course of FA of a potent inhaled anesthetic gen-
erated by a physiological uptake model (Gas Man®) can be
equally well described using a classical three compart-
mental model derived from data generated by the very
same physiological model (Gas Man®). While the rela-
tionship between the distribution volumes and clearances
and organ capacities and tissue blood flows is complex, it
is nevertheless intuitively tempting to try to explain e.g.
the associations between a decrease in cardiac output and
the changes in the volumes of distribution in terms of
alterations in tissue blood flow of distributions. Yasuda
and colleagues used NONMEM derived classical compart-
mental parameters from end-expired concentrations and
related the parameters of the exponential curves (expo-
nents and time constants) to known physiological proc-
esses and anatomical compartments [9]. These parameters
were subsequently used to help delineate several physio-
logical compartments: the first, second, third, fourth, and
fifth compartment were interpreted as representing lungs,
Structural parameters for each of the four agents in a 70 kg patient with a cardiac output ranging from 2 to 10 L.min-1 for a  115 min wash-in and wash-out period Figure 1
Structural parameters for each of the four agents in a 70 kg patient with a cardiac output ranging from 2 to 10 



































































































V1-V3: volumes of distribution; CL1-CL3: clearances.
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vessel rich group, muscle group, intertissue diffusion, and
the fat group. Hull, however, acclaims that while it is often
suggested that some particular tissue or organ (such as the
brain) be 'in' one compartment or another, such sugges-
tions are ill-founded because parameters of the fit to the
uptake data contain no information that might support
such assumptions [10,11]. Similarly, Wissing argues that
a precise allocation of several hypothetical peripheral
compartments to anatomical defined tissues is hardly fea-
sible [2,3].
If it is true that distribution volumes and clearances can be
directly interpreted in terms of tissue volumes and tissue
blood flows, a change in weight or cardiac output that is
known to cause proportional changes in tissue volumes or
tissue blood flow in the (physiological) model of Gas
Man® should also cause proportional changes in the distri-
bution volumes and clearances of the empirical compart-
mental (NONMEM) model. In our current simulations,
an increase in cardiac output and weight does indeed
increase clearance and distribution volume (Figures 1 and
2). However, this type of relationship is not consistent. An
increase in cardiac output is associated with a decrease in
the clearance of V2 (the second compartment) with
sevoflurane and isoflurane. In addition, the non-linear
(almost hyperbolic) relationship between V3 (the third
compartment) and cardiac output for all four gases can-
not be interpreted in terms of an underlying physiological
model or process. Therefore, the parameters of the under-
lying physiological model (organ capacities and blood
flows) and those of an empirical model (distribution vol-
umes and clearances) therefore cannot be interpreted in
terms of one another.
We have shown that the kinetics of anesthetic gases can be
described by a mammilary model. Therefore, concepts
that are traditionally thought of as being applicable to the
kinetics of intravenous agents can be equally well applied
to anesthetic gases. One example of one of these concepts
are context sensitive half-times, which interestingly had
been described for inhaled agents before the term context
sensitive half-time was introduced but were labeled
"coasting times" by Lowe and Ernst [12,13].
This study does not address when or whether to use phys-
iological modeling or classical compartmental modeling.
Either modeling approach adequately describes and pre-
dicts the course of FA, but their parameters cannot be
interpreted in terms of one another. A three compartment
model can be a good fit of a concentration that is effec-
tively the sum of a multi-organ (physiological) system,
where each organ displays first order kinetics [14]. This
study does not address the validity of the GasMan® model
either. Even though GasMan® can be used to gain addi-
tional insights into the kinetic of inhaled agents, clinical
validation of the GasMan® model is lacking.
Table 2: Goodness of fit for the predictions by three 
compartment model predictions during model derivation and 
prospective testing.
Model derivation Prospective testing
MDPE MDAPE MDPE MDAPE
Halothane 0.00 0.18 0.31 0.38
Isoflurane 0.00 0.29 0.38 0.52
Sevoflurane 0.00 0.63 0.27 0.73
Desflurane 0.00 0.74 0.51 1.51
MDPE = median prediction error; MDAPE = median absolute 
prediction error. Values are expressed in %.
Table 1: The pharmacokinetic parameters for the three 
compartmental model with cardiac output (CO, L.min-1) and 
weight (WT, kg) as covariates (tested for parsimony).
Halothane
V1 = 5.65 + 0.020(WT-70) + 0.68(CO-5)
V2 = 8.35 + 0.15(WT-70) - 0.49(CO-5)
V3 = 134.09 + 1.91(WT-70)
CL1 = 1.23 + 0.050(CO-5)
CL2 = 2.57 + 0.010(WT-70) + 0.47(CO-5)
CL3 = 0.87 + 0.17(CO-5)
Isoflurane
V1 = 4.21 + 0.020(WT-70) + 0.39(CO-5)
V2 = 3.16 + 0.065(WT-70) - 0.31(CO-5)
V3 = 61.40 + 0.87(WT-70)
CL1 = 1.12 + 0.024(CO-5)
CL2 = 1.05 + 0.0037(WT-70) + 0.17(CO-5)
CL3 = 0.46 + 0.092(CO-5)
Sevoflurane
V1 = 3.33 + 0.018(WT-70) + 0.21(CO-5)
V2 = 1.51 + 0.033(WT-70) - 0.18(CO-5)
V3 = 33.69 + 0.47(WT-70)
CL1 = 1.05 + 0.011(CO-5)
CL2 = 0.37 + 0.0034(WT-70) + 0.053(CO-5)
CL3 = 0.23 + 0.046(CO-5)
Desflurane
V1 = 2.94 + 0.017(WT-70) + 0.14(CO-5)
V2 = 1.56 + 0.030(WT-70) - 0.14(CO-5)
V3 = 14.08 + 0.19(WT-70)
CL1 = 1.03 + 0.0066(CO-5)
CL2 = 0.25 + 0.0022(WT-70) + 0.036(CO-5)
CL3 = 0.14 + 0.029(CO-5)
V = distribution volume (L), CL = clearance (L.min-1), with numbers 
1, 2, and 3 referring to the first, second, and third compartment.BMC Anesthesiology 2006, 6:7 http://www.biomedcentral.com/1471-2253/6/7
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Conclusion
We describe how non-linear mixed-effect modeling can be
used to derive a three compartmental empirical model to
describe the kinetic behavior of potent inhaled anesthetic
generated by a physiological model (Gas Man®). There-
fore, concepts that are traditionally thought of as being
applicable to the kinetics of intravenous agents can be
equally well applied to anesthetic gases. The relationship
between the distribution volumes and clearances of the
empirical model and tissue capacities and blood flow of
the physiological model are complex, however. Our study
reinforces the fact that the compartmental models (even
with co-variate models) are an empirical description of a
data set, and that the parameters have virtually no physi-
ological interpretation.
Appendix. Graphical display and formulas of the 
empirical three-compartmental model 
(NONMEM) and the physiological model of Gas 
Man®
The empirical three-compartmental model (NONMEM)
With a three compartmental model, the time course of the
drug's concentration can be described in three mathemat-
ically equivalent ways: (a) three volumes and three clear-
ances; (b) five rate constants and a scaling factor; or (c) a
tri-exponential equation. The volume-clearance scheme is
useful to visualize how the drug moves throughout the
body (figure 4A). In the rate constant-scaling factor
scheme (figure 4B) each "micro-rate constant" kij defines
the rate of drug transfer from one compartment i to
another compartment j. V1 is the scaling factor; V2 and V3
are not independent parameters here. The mathematical
form of the three-compartment exponential equation is
most commonly used (figure 4C). A, B, and C are called
"coefficients"; α, β, and γ (occasionally called λ1, λ2, and
λ3) are "exponents" or "hybrid rate constants". While the
volume-clearance and the rate constant-scaling factor
scheme parameters are mathematically easily converted
into one another [8], the coefficients and exponentials of
the tri-exponential fit are related to the volumes and clear-
ances and to the rate constants and scaling factor in a
slightly more complex manner.
By using a sum of least squares method (the minimum
objective function or MOF), NONMEM determines
whether a one, two or three compartmental model best
describes the concentration course. Depending on the
type of control file used, NONMEM analysis will yield
either the exponents and coefficients or distribution vol-
umes and clearances. The best fitting model is then opti-
mized by mathematically linking patient covariates (e.g.
weight, height, cardiac output) to those parameters, again
Structural parameters for each of the four agents in a patient with a cardiac output of 5 L.min-1 and weight ranging from 40 to  100 kg for a 115 min wash-in and wash-out period Figure 2
Structural parameters for each of the four agents in a patient with a cardiac output of 5 L.min-1 and weight ranging from 40 to 








































































































V1-V3: volumes of distribution; CL1-CL3: clearances.
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using the MOF to decide whether or not a covariate signif-
icantly improves the fit.
The physiological model of Gas Man®
The building blocks for the physiological model of Gas
Man® are also labeled "compartments". In Gas Man®, the
patient is modeled as four compartments: the lung, vessel
rich group, muscle and fat; the circuit is a fifth. Each
patient compartment refers to a group of tissues for which
uptake can be described by a differential equation if tissue
volume, tissue flow, and tissue solubility are known. The
model assumes that anesthetic uptake by an organ is a
perfusion-limited, exponential process. Organ vapor
capacity depends on the size of the organ and the solubil-
ity of the agent in that particular organ. The rate at which
the partial pressure in the organ increases, and eventually
saturates (=equals the partial pressure in the arterial
blood), depends both on the organ's capacity (the more
can be stored at the same partial pressure, the longer this
will take), and on organ blood flow (the higher blood
flow, the faster it will equilibrate with the arterial partial
pressure, and therefore the faster it saturates). Based on
both tissue storage capacity and blood flow, organs and
tissue groups are grouped into the VRG, MG, and FG
group (vessel rich group, muscle group, and fat group,
respectively). The Gas Man®  simulation uses Euler's
method of solution for the simultaneous differential
equations, with linear coefficients that govern the five-
compartment system. The model utilizes standard values
for organ volumes, anesthetic solubilities, and regional
blood flows. An example of the actual display is depicted
in figure 5.
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Prospective testing of the model: the end-expired concentrations (FA) predicted by the compartmental model (full line) and  the corresponding values simulated by Gas Man® (open circles) for halothane (A), isoflurane (B), sevoflurane (C), and desflu- rane (D) Figure 3
Prospective testing of the model: the end-expired concentrations (FA) predicted by the compartmental model (full line) and 
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A. The three compartment empirical model: the volume-clearance scheme Figure 4
A. The three compartment empirical model: the volume-clearance scheme. B. The three compartment empirical model: the 
rate constant-scaling factor scheme. C. The three compartment empirical model: the mathematical three exponential scheme.
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